skip to Main Content
 
October 21, 2020 1:00 - 2:00 PM ET

What’s Next for Oncology Care Management and Payment?

  • This page as PDF

Summary

Avalere experts took a closer look at emerging oncology trends, innovative approaches to payment and delivery, and what these changes will mean for patient access.

Sophisticated treatment advancements will continue to evolve how oncology stakeholders define value and manage cancer care during and after COVID-19. Join Avalere experts as they take a closer look at emerging trends, innovative approaches to payment and delivery, and what these changes will mean for patient access.

Key Topics

  • COVID-19 impacts on oncology care delivery, cost, and outcomes
  • Oncology payment and delivery reform amid a public health emergency
  • Managing and paying for emerging therapies and cancer combo regimens
  • 2020 election implications for the future of oncology care

Panelists

Moderator
Sarah Butler , Head, Client Solutions, Marketing & Operations

Sarah Butler specializes in evidence-based medicine, value-based contracting, and strategy development.

Speaker
Lance Grady , Practice Director, Market Access & Reimbursement

As the leader of the Market Access Practice, Lance Grady devises commercialization strategies focused on value, access, and reimbursement.

Speaker
Milena Sullivan , Principal, Policy

Milena Sullivan advises life sciences clients on the impact of the evolving healthcare policy landscape on their commercial, access, and advocacy priorities.

Guest Speaker
Roy Beveridge, MD , Senior Advisor, Avalere Health
Dr Beveridge is part of Avalere’s Commercialization and Regulatory Strategies team and helps as a senior advisor; He is a medical oncologist who has been in practice for more than 20 years.
From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about Value-Based Care
Please enter your email address to be notified when new Value-Based Care insights are published.

Back To Top